Replies to post #197626 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Dilution has been. MINIMAL! For a company to go from 0 clinical trials to 8 and bring 3 of those trials to "possibly" phase 3 by end of year!!!! Ummmmm and go from about 95 million shares to 137 million over 5 years is NOTHING! Absolutely nothing in comparisons to all other biotech. I BET you could not find ONE company out there that has made the progress that IPIX has and compare share structure increase.

0 human clinical trials to 8 human clinical trials. 1 is ready to move to phase 3. The other two phase 2 and 2b trials will complete this year.

Not to mention the market potential for all of IPIX pipeline. We are talking unmet need in the billions on some.

Kevetrin will reemerge soon. And it will be on every news channel in the country. Jmo.

Keep adding thru year end at these unbelievable prices. Just ONE collaboration and we go from sub dollar to double digits - mark it

[TheBunny]

Now you know that here, that is all Good News developments.

we've heard about 'catalysts' for the past 3 years: name change, December 2016 trials, February 2017 trials, May results, August results and September results. and we sit at 5 year lows.

December 2017 will come and go with just more Aspire selling

Where SP doesn't matter, or the missed time frames, constantly moved Goal Posts, and the plain UN-uplisting by Der Leo, and his Yes Der Leo- BoD's.
In this world, Der Leo, deserves a salary raise.

60's , 50's - 40's CENTS per share.... they don't care. It's all about - The Partnership and that is, as you well know.....just around the corner, after a few more tiny tweaks and indications.

Just STAY THE COURSE. Buy early, buy often, Average Down and be happily awaiting the KA-BooM !